As one of the US’ largest and most consumer-driven industries, healthcare is poised for significant M&A activity and investments. From consolidation within fragmented sub-sectors to “capabilities building” to improve quality of care and reduce costs, healthcare doubtless will remain exceptionally dynamic in all respects for the foreseeable future.
The McLean Group’s Healthcare team assists middle market healthcare companies with their growth and development by providing exceptional expertise in M&A and capital formation services. From identifying suitable acquisition targets to augment organic growth or build strategic capabilities, to providing advice on how to maximize the value owners realize when selling their businesses, to raising capital from private institutional sources to scale up operations, our Healthcare team focuses on helping our clients realize the best opportunities to achieve their specific goals.
We focus on the following industry sub-sectors:
| |
|
| |
- Healthcare Information Technology |
| |
- Medical Devices |
| |
- Biotechnology |
| |
- Other Healthcare Services |
Our Healthcare team brings a wealth of transaction, capital markets and industry-specific experience to help clients execute their M&A strategies. Clients served include small, midsize and large healthcare companies:
| |
|
|
| |
- 3M Health Care |
- Eli Lilly |
| |
- Abbott Laboratories |
- Genesis Eldercare |
| |
- Blue Cross-Blue Shield of Maryland |
- Hillenbrand Industries |
| |
- Bristol-Myers Squibb |
- J&J Life Technologies |
| |
- Caremark, Inc. |
- Penwest Pharmaceuticals |
| |
- CIGNA |
- Pioneer Life Insurance |
| |
- CNA Insurance |
- Reynolds & Reynolds Co. |
| |
- CUNA Mutual |
- Shared Medical Systems |
| |
- Delta Dental Insurance |
|
We are committed to providing our healthcare clients expert M&A advice and capital access ideas and solutions.
Healthcare Practice Lead:
Enrique C. Brito, CFA, AVA, CM&A, CMAP
Senior Managing Director
703-827-5093 (direct)
ebrito@mcleanllc.com